跳至主要内容
临床试验/ISRCTN03484127
ISRCTN03484127已完成不适用

Cystic fibrosis: a hereditary inflammatory process

niversity Medical Centre Utrecht (UMCU) (The Netherlands)0 个研究点目标入组 60 人开始时间: 2005年9月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • For 3-years randomised controlled trial:
  • 1. CF diagnosis as confirmed by sweat chloride test and/or genotyping
  • 2. CF-patients 2 - 10 years old
  • 3. Informed consent
  • 4. Capable of using inhaled corticosteroids by aerochamber
  • 5. Compliant to regular therapy

排除标准

  • For 3-years randomised controlled trial:
  • 1. CF-patients less than 2 years
  • 2. CF-patients greater than 10 years
  • 3. Use of anti-inflammatory therapy in a period of 2 months before inclusion (orally administered steroids, inhaled corticosteroids and non-steroid anti-inflammatory drugs, non-steroidal anti-inflammatory drugs [NSAIDs])
  • 4. Disease, other than CF, that affects growth
  • 5. Participation in another study

研究者

发起方
niversity Medical Centre Utrecht (UMCU) (The Netherlands)

相似试验